Oral health of the methamphetamine abuser

American Journal of Health-System Pharmacy

Volumn 63, Issue 21, 2006, Pages 2078-2082

  Donaldson, Mark ^a,b   Goodchild, Jason H ^c,d  

^a KALISPELL REGIONAL MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Drug abuse; Fluorides; Mechanism of action; Methamphetamine; Mouth diseases; Oral health; Patient information; Pharmacists; Toxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; CEVIMELINE; CIMETIDINE; CITALOPRAM; DEXAMETHASONE; DRY MOUTH GUM; DRY MOUTH TOOTHPASTE; FLUORIDE; FLUORIDE SODIUM; GENTLE MOUTHWASH; KARIGEL; LOCAL ANESTHETIC AGENT; METHAMPHETAMINE; METHYLPHENIDATE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPTIMOIST; ORAL BALANCE GEL; PAROXETINE; PILOCARPINE; SERTRALINE; TOOTHPASTE; TRAMADOL; VASOCONSTRICTOR AGENT;

BRUXISM; CARBONATED BEVERAGE; CARDIOVASCULAR DISEASE; DENTAL CARIES; DENTITION; DRUG INTOXICATION; DRUG MECHANISM; DRUG METABOLISM; EUPHORIA; FLUID INTAKE; HUMAN; HYPERACTIVITY; MOUTH HYGIENE; PATIENT COUNSELING; PATIENT INFORMATION; PRIORITY JOURNAL; REVIEW; SALIVATION; SIDE EFFECT; SUBSTANCE ABUSE; SUPPLEMENTATION; TOOTH DISEASE; TOOTH PAIN; XEROSTOMIA;

EID: 33751058172     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060198     Document Type: Review

References (44)

1. Logan BK. Amphetamines: an update on forensic issues. J Anal Toxicol. 2001; 25:400-4.
2. Greater Dallas Council on Alcohol and Drug Abuse. Methamphetamine. www.gdcada.org/statistics/meth/meth2.htm (accessed 2005 Feb 17).
3. The Vaults of Erowid. Methamphetamine timeline. www.erowid.org/chemicals/ meth/meth_timeline.php (accessed 2006 Apr 10).
4. Drug Enforcement Administration. Comprehensive Drug Abuse Prevention and Control Act of 1970. www.dea.gov/pubs/csa.html (accessed 2006 Jun 8).
5. Davey M. Grisly effect of one drug: 'meth mouth.' http://vadental.org/ docs/timesarticlemeth.pdf (accessed 2005 Dec 12).
6. Brunswick M. Meth users can look forward to gumming their food. http://dpna.org/resources/druginfo/methgums.htm (accessed 2005 Dec 6).
7. Jefferson DJ. America's most dangerous drug, www.msnbc.msn.com/id/8770112 (accessed 2005 Dec 6).
8. Kinkead LD, Romboy D. Meth mouth: ugly legacy of drug is taxing Utah jail, prison medical budgets. http://deseretnews.com/dn/view/0,1249,600140819, 00.html (accessed 2006 Feb 13).
9. American Dental Association. Methamphetamine use and oral health. J Am Dent Assoc. 2005; 136:1491.
10. Rhodus NL, Little JW. Methamphetamine abuse and "meth mouth." Northwest Dent. 2005; 84:29,31,33-7.
11. Venker D. Crystal methamphetamine and the dental patient. Iowa Dent J. 1999; 85:34.
12. Shaner JW. Caries associated with methamphetamine abuse. J Mich Dent Assoc. 2002; 84:42-7.
13. American Dental Association. Methamphetamine use (meth mouth), www.ada.org/prof/resources/topics/methmouth.asp (accessed 2006 Feb 13).
14. Jones KD. Viewpoint: spotting meth mouth, www.ada.org/prof/resources/ pubs/adanews/adanewsarticle.asp?articleid=1517 (accessed 2006 Feb 13).
15. Palmer C. Special report: "meth mouth" tells devastating story, www.ada.org/prof/resources/pubs/adanews/adanewsarticle.asp?articleid=1523 (accessed 2005 Dec 6).
16. Palmer C. Dr. Brandjord briefs senators on dental impact of meth abuse, www.ada.org/prof/resources/pubs/adanews/adanewsarticle.asp?articleid=1764 (accessed 2006 Feb 13).
17. Hoffman BB. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001:215-60.
18. Lacey CF, Goldman MP, Lanci LL et al. Drug information handbook. 13th ed. Hudson, OH: Lexi-Comp; 2005:971-2.
19. Lee CYS, Heffez LB, Mohammadi H. Crystal methamphetamine abuse: a concern to oral and maxillofadal surgeons. J Oral Maxillofac Surg. 1992; 50:1052-4.
20. Office of National Drug Control Policy. Methamphetamine. http://whitehousedrugpolicy.org/publications/pdf/ncj197534.pdf (accessed 2006 Jul 31).
21. Schepers RJ, Oyler JM, Joseph RE Jr et al. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003; 49:121-32.
22. Alberta Alcohol and Drug Abuse Commission. Amphetamines. http://corp.aadac.com/content/corporate/other_drugs/amphetamines_beyond_abcs. pdf (accessed 2006 Jul 31).
23. Lineberry TW, Bostwick JM. Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc. 2006; 81:77-84.
24. Scandling J, Spital A. Amphetamine-associated myoglobinuric renal failure. South Med J. 1982; 75:237-40.
25. Olkkola KT, Ahonen J. Drug interactions. Curr Opin Anaesthesiol. 2001; 14:411-6.
26. Sweeney BP, Bromilow J. Liver enzyme induction and inhibition: implications for anaesthesia. Anaesthesia. 2006; 61:159-77.
27. Williams F, Turner T. Adrenergic pharmacology. In: Golan DE, Taschijian AH, Armstrong EJ et al., eds. Principles of pharmacology. The pathophysiologic basis of drug therapy. Baltimore: Lippincott Williams and Wilkins; 2005:107-17.
28. Navarro M, Pichini S, Farre M et al. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin Chem. 2001; 47:1788-95.
29. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. http://oas.samhsa.gov/nsduh.htm (accessed 2006 Feb 14).
30. Centers for Disease Control and Prevention. Youth risk behavior surveillance-United States, 2001. www.cdc.gov/mmwr/preview/mmwrhtml/ss5104a1.htm (accessed 2006 Feb 14).
31. Forest D. Methamphetamine and oral health: reality or myth. J Dent Que. 2005; 42:445.
32. Shafer J. The meth-mouth myth. www.slate.com/id/2124160/ (accessed 2005 Dec 6).
33. Lewis DM. Xerostomia: a clinical approach. J Okla Dent Assoc. 2005; 97:22-5.
34. Saini TS, Edwards PC, Kimmes NS et al. Etiology of xerostomia and dental caries among methamphetamine abusers. Oral Health Prev Dent. 2005; 3:189-95.
35. Curtis EK. Meth mouth: a review of methamphetamine abuse and its oral manifestations. Gen Dent. 2006; 54:125-9.
36. McDaniel TF, Miller D, Jones R et al. Assessing patient willingness to reveal medical history information. J Am Dent Assoc. 1995; 126:375-9.
37. [Erratum, J Am Dent Assoc. 1995; 126:560.]
38. BC Partners for Mental Health and Addictions Information. Methamphetamine. www.heretohelp.bc.ca (accessed 2006 Feb 14).
39. Newton TF, De La Garza R II, Kalechstein AD et al. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol Biochem Behav. 2005; 82:90-7.
40. American Dental Association. ADA warns of methamphetamine's effect on oral health, www.ada.org/public/media/releases/0508_release01.asp (accessed 2006 Jul 27).
41. Givens E. Update on xerostomia: current treatment modalities and future trends. Gen Dent. 2006; 54:99-101.
42. Grisius MM. Salivary gland dysfunction: a review of systemic therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92:156-62.
43. Rhodus NL, Bereuter J. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjogren's syndrome. J Otolaryngol. 2000; 29:28-34.
44. Warde P, Kroll B, O'Sullivan B et al. A Phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Support Care Cancer. 2000; 8:203-8.